CD molecules 2005: Human cell differentiation molecules

Heddy Zola; Bernadette Swart; Ian Nicholson; Bent Aasted; Armand Bensussan; Laurence Boumsell; Chris Buckley; Georgina Clark; Karel Drbal; Pablo Engel; Derek Hart; Václav Horejsí; Clare Isacke; Peter Macardle; Fabio Malavasi; David Mason; Daniel Olive; Armin Saalmueller; Stuart F. Schlossman; Reinhard Schwartz-Albiez; Paul Simmons; Thomas F. Tedder; Mariagrazia Uguccioni; Hilary Warren

doi:10.1182/blood-2005-03-1338

CD molecules 2005: Human cell differentiation molecules

Heddy Zola^*, Bernadette Swart, Ian Nicholson, Bent Aasted, Armand Bensussan, Laurence Boumsell, Chris Buckley, Georgina Clark, Karel Drbal, Pablo Engel, Derek Hart, Václav Horejsí, Clare Isacke, Peter Macardle, Fabio Malavasi, David Mason, Daniel Olive, Armin Saalmueller, Stuart F. Schlossman, Reinhard Schwartz-AlbiezPaul Simmons, Thomas F. Tedder, Mariagrazia Uguccioni, Hilary Warren

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

102 Citations (Scopus)

Abstract

The immune system works through leukocytes interacting with each other, with other cells, with tissue matrices, with infectious agents, and with other antigens. These interactions are mediated by cell-surface glycoproteins and glycolipids. Antibodies against these leukocyte molecules have provided powerful tools for analysis of their structure, function, and distribution. Antibodies have been used widely in hematology, immunology, and pathology, and in research, diagnosis, and therapy. The associated CD nomenclature is commonly used when referring to leukocyte surface molecules and antibodies against them. It provides an essential classification for diagnostic and therapeutic purposes. The most recent (8th) Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA), held in Adelaide, Australia, in December 2004, allocated 95 new CD designations and made radical changes to its aims and future operational strategy in order to maintain its relevance to modern human biology and clinical practice.

Original language	English
Pages (from-to)	3123-3126
Number of pages	4
Journal	Blood
Volume	106
Issue number	9
DOIs	https://doi.org/10.1182/blood-2005-03-1338
Publication status	Published - Nov 2005

Access to Document

10.1182/blood-2005-03-1338

Cite this

Zola, H., Swart, B., Nicholson, I., Aasted, B., Bensussan, A., Boumsell, L., Buckley, C., Clark, G., Drbal, K., Engel, P., Hart, D., Horejsí, V., Isacke, C., Macardle, P., Malavasi, F., Mason, D., Olive, D., Saalmueller, A., Schlossman, S. F., ... Warren, H. (2005). CD molecules 2005: Human cell differentiation molecules. Blood, 106(9), 3123-3126. https://doi.org/10.1182/blood-2005-03-1338

@article{9bd7c607931d449cb466b2403e52f7f6,

title = "CD molecules 2005: Human cell differentiation molecules",

abstract = "The immune system works through leukocytes interacting with each other, with other cells, with tissue matrices, with infectious agents, and with other antigens. These interactions are mediated by cell-surface glycoproteins and glycolipids. Antibodies against these leukocyte molecules have provided powerful tools for analysis of their structure, function, and distribution. Antibodies have been used widely in hematology, immunology, and pathology, and in research, diagnosis, and therapy. The associated CD nomenclature is commonly used when referring to leukocyte surface molecules and antibodies against them. It provides an essential classification for diagnostic and therapeutic purposes. The most recent (8th) Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA), held in Adelaide, Australia, in December 2004, allocated 95 new CD designations and made radical changes to its aims and future operational strategy in order to maintain its relevance to modern human biology and clinical practice.",

author = "Heddy Zola and Bernadette Swart and Ian Nicholson and Bent Aasted and Armand Bensussan and Laurence Boumsell and Chris Buckley and Georgina Clark and Karel Drbal and Pablo Engel and Derek Hart and V{\'a}clav Horejs{\'i} and Clare Isacke and Peter Macardle and Fabio Malavasi and David Mason and Daniel Olive and Armin Saalmueller and Schlossman, {Stuart F.} and Reinhard Schwartz-Albiez and Paul Simmons and Tedder, {Thomas F.} and Mariagrazia Uguccioni and Hilary Warren",

year = "2005",

month = nov,

doi = "10.1182/blood-2005-03-1338",

language = "English",

volume = "106",

pages = "3123--3126",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "9",

}

Zola, H, Swart, B, Nicholson, I, Aasted, B, Bensussan, A, Boumsell, L, Buckley, C, Clark, G, Drbal, K, Engel, P, Hart, D, Horejsí, V, Isacke, C, Macardle, P, Malavasi, F, Mason, D, Olive, D, Saalmueller, A, Schlossman, SF, Schwartz-Albiez, R, Simmons, P, Tedder, TF, Uguccioni, M & Warren, H 2005, 'CD molecules 2005: Human cell differentiation molecules', Blood, vol. 106, no. 9, pp. 3123-3126. https://doi.org/10.1182/blood-2005-03-1338

TY - JOUR

T1 - CD molecules 2005

T2 - Human cell differentiation molecules

AU - Zola, Heddy

AU - Swart, Bernadette

AU - Nicholson, Ian

AU - Aasted, Bent

AU - Bensussan, Armand

AU - Boumsell, Laurence

AU - Buckley, Chris

AU - Clark, Georgina

AU - Drbal, Karel

AU - Engel, Pablo

AU - Hart, Derek

AU - Horejsí, Václav

AU - Isacke, Clare

AU - Macardle, Peter

AU - Malavasi, Fabio

AU - Mason, David

AU - Olive, Daniel

AU - Saalmueller, Armin

AU - Schlossman, Stuart F.

AU - Schwartz-Albiez, Reinhard

AU - Simmons, Paul

AU - Tedder, Thomas F.

AU - Uguccioni, Mariagrazia

AU - Warren, Hilary

PY - 2005/11

Y1 - 2005/11

N2 - The immune system works through leukocytes interacting with each other, with other cells, with tissue matrices, with infectious agents, and with other antigens. These interactions are mediated by cell-surface glycoproteins and glycolipids. Antibodies against these leukocyte molecules have provided powerful tools for analysis of their structure, function, and distribution. Antibodies have been used widely in hematology, immunology, and pathology, and in research, diagnosis, and therapy. The associated CD nomenclature is commonly used when referring to leukocyte surface molecules and antibodies against them. It provides an essential classification for diagnostic and therapeutic purposes. The most recent (8th) Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA), held in Adelaide, Australia, in December 2004, allocated 95 new CD designations and made radical changes to its aims and future operational strategy in order to maintain its relevance to modern human biology and clinical practice.

AB - The immune system works through leukocytes interacting with each other, with other cells, with tissue matrices, with infectious agents, and with other antigens. These interactions are mediated by cell-surface glycoproteins and glycolipids. Antibodies against these leukocyte molecules have provided powerful tools for analysis of their structure, function, and distribution. Antibodies have been used widely in hematology, immunology, and pathology, and in research, diagnosis, and therapy. The associated CD nomenclature is commonly used when referring to leukocyte surface molecules and antibodies against them. It provides an essential classification for diagnostic and therapeutic purposes. The most recent (8th) Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA), held in Adelaide, Australia, in December 2004, allocated 95 new CD designations and made radical changes to its aims and future operational strategy in order to maintain its relevance to modern human biology and clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=24744447579&partnerID=8YFLogxK

U2 - 10.1182/blood-2005-03-1338

DO - 10.1182/blood-2005-03-1338

M3 - Article

SN - 0006-4971

VL - 106

SP - 3123

EP - 3126

JO - Blood

JF - Blood

IS - 9

ER -

CD molecules 2005: Human cell differentiation molecules

Abstract

Access to Document

Other files and links

Fingerprint

Cite this